The number of special access approvals has shot up by hundreds over the past few months The TGA has released its latest data on the use of unapproved medicinal cannabis products in Australia. Such products can be accessed through the Authorised Prescriber Scheme (AP), the Special Access Scheme (SAS) and through clinical trials. When products
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.